Login Get Started
Browse
Shares
Healthcare
Healthcare Providers & Services
BioCorRx Inc
BioCorRx Inc logo

BICX - BioCorRx Inc Share News

$1.95 0.1  2.6%

Last Trade - 25/02/21

Sector
Healthcare
RiskRating
Speculative
Size
Micro Cap
Style
Sucker Stock
Market Cap £7.29m
Enterprise Value £6.85m
Revenue £115k
Position in Universe 6248th / 6713
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions BICX Dividends
All News
All News Reuters News Company Announcements
BRIEF-BioCorRx Appoints Finance Veteran Joseph J. Galligan To Board Of Directors
Wed 2:15pm News
BioCorRx Appoints Finance Veteran Joseph J. Galligan to the Board of Directors
Wed 1:30pm News
BioCorRx Announces Update on NIDA Grant and Development of Naltrexone Implant for the Treatment of Opioid and Alcohol Use Disorders
15th Jan News
BioCorRx Provides Business Update for the Third Quarter of 2020; BioCorRx Subsidiary, BioCorRx Pharmaceuticals Inc. Progressing with Pivotal Nonclinical BICX102 Study
16th Nov '20 News
BioCorRx Partners with Truusight Health to Integrate Recovery Program Into Self-Funded Health Plans
13th Oct '20 News
BioCorRx Provides Business Update for the Second Quarter of 2020
14th Aug '20 News
BRIEF-BioCorRx Inc Says GLP Preclinical Studies Uninterrupted By COVID-19 To Date
22nd May '20 News
BioCorRx Provides Update on Current Business Operations and on GLP Studies of BICX102; Uninterrupted by COVID-19 Pandemic
22nd May '20 News
BioCorRx Offers Free Access to the UnCraveRx™ Mobile Platform for Weight Loss Management During COVID-19 Pandemic
10th Apr '20 News
BioCorRx Offers Free Access to the BioCorRx Recovery Program Mobile Platform for Medical Professionals During COVID-19 Pandemic
7th Apr '20 News
BioCorRx Provides Business Update; Pivotal GLP Study of BICX102 Uninterrupted by COVID-19 Pandemic
31st Mar '20 News
BioCorRx Announces Senior Management Promotions
2nd Mar '20 News
BioCorRx Announces Award of $2.8 Million, the Second Tranche of a NIDA Grant for the Development of BICX102, a Sustained Release Naltrexone Implant for the Treatment of Opioid Use Disorder
30th Jan '20 News
BioCorRx Provides 2019 Year-End Business Update
19th Dec '19 News
BRIEF-BioCorRx Preclinical Data Suggests VDM-001 May Prevent Fentanyl Overdose
3rd Dec '19 News
BioCorRx’s Subsidiary, BioCorRx Pharmaceuticals Provides Update on Potential Overdose Reversal Drug Candidate VDM-001
3rd Dec '19 News
BioCorRx Announces UnCraveRx™ a Medically-Assisted Weight Loss Program as Sponsor and Exhibitor at the 36th Annual American Society of Metabolic and Bariatric Society Meeting
30th Oct '19 News
BioCorRx Announces the Official Launch of UnCraveRx, a Medically-Assisted Weight Loss Management Program
8th Oct '19 News
BioCorRx Announces Capital Restructuring and Provides Business Update
7th Oct '19 News
BioCorRx Provides Business Update for the Third Quarter of 2018
14th Nov '18 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.